Is Biotech Acting More Than A Bit Like Bitcoin?
New Biotech World Order – surging share prices and booming initial public offerings of biotech stocks.
Stock Market
“The Most Growth, At The Cheapest Price”
What are the most affordable biopharmaceutical growth stocks in the S&P 500 right now? Or, as today’s article puts it, which biopharma stocks in the… Read More »“The Most Growth, At The Cheapest Price”
3 Reasons This Could Be “The Best Biotech Stock You Can Buy At The Moment”
Why might the stock highlighted in today’s article – shares of which have more than tripled investors’ money over the past year – be the… Read More »3 Reasons This Could Be “The Best Biotech Stock You Can Buy At The Moment”
There’s Good Reason To Watch These 5 Biotech Penny Stocks This Quarter
When it comes to the five biotech penny stocks to watch this quarter highlighted in today’s article, the author emphasizes that “These aren’t just names… Read More »There’s Good Reason To Watch These 5 Biotech Penny Stocks This Quarter
10 Under $10: The Best Small-Cap Biotech Stocks For 2021
While large-cap biotech stocks may come with less risk than their small-cap counterparts, the author of today’s article notes that “On the plus side small-cap… Read More »10 Under $10: The Best Small-Cap Biotech Stocks For 2021
3 Biotech Stocks To Watch – Including A Pioneering CBD Company
Among the three biotech stocks to watch going forward in 2021 highlighted by the author of today’s article is a specialty company focused on developing… Read More »3 Biotech Stocks To Watch – Including A Pioneering CBD Company
On The Cusp Of Commercializing Its First Drug, Now May Be The Time To Buy This Biotech Stock
When it comes to investing in biotech stocks, the author of today’s article points out that “By identifying companies that are likely to report rapid… Read More »On The Cusp Of Commercializing Its First Drug, Now May Be The Time To Buy This Biotech Stock
Biotech/Pharma Stocks To Watch In The First Days Of February
The final week of January was yet another big one for biotech, with perhaps the most important development of the week being phase III trial results for Novavax’s COVID-19 vaccine.
Why Now Is The Time To Invest In The Genomic Revolution – And A Highly Specialized Play To Do Just That
The genomic revolution in underway, with the author of today’s article noting that “artificial intelligence is converging with decades of breakthrough genomics research to create a new generation of hyper-efficient, hyper-accurate, and hyper-precise gene editing medicines.”
This Biotech Laggard Could Offer Traders A Market-Beating Opportunity
When it comes to the performance of healthcare companies during the pandemic, the author of today’s article notes that “Those best prepared for developing a… Read More »This Biotech Laggard Could Offer Traders A Market-Beating Opportunity